Can Farxiga (dapagliflozin) cause diarrhea?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 27, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Can Farxiga (Dapagliflozin) Cause Diarrhea?

Diarrhea is not a direct adverse effect of Farxiga (dapagliflozin), but the FDA label mentions diarrhea only in the context of fluid loss that can worsen dehydration—a known risk with this medication. 1

Understanding the Relationship

The FDA medication guide for Farxiga specifically instructs patients to contact their healthcare provider if they "start to lose liquids from your body, for example from vomiting, diarrhea, or being in the sun too long" 1. This mention is not identifying diarrhea as a side effect of the drug itself, but rather warning that if diarrhea occurs from any cause, it can compound the volume depletion risk that SGLT2 inhibitors already create.

What This Means Clinically

The key distinction is that Farxiga causes volume depletion through increased urinary glucose and sodium excretion, not through gastrointestinal effects. The primary adverse effects documented in clinical trials and FDA labeling are:

  • Genital mycotic infections (most common, especially in women) 2, 3, 4
  • Urinary tract infections 2, 5
  • Volume depletion/dehydration leading to orthostatic hypotension 1
  • Diabetic ketoacidosis (rare but serious) 1
  • Fournier's gangrene (rare necrotizing fasciitis of the perineum) 1, 2

Clinical Implications

If a patient on Farxiga develops diarrhea:

  • Investigate other causes of diarrhea (infection, dietary changes, other medications, metformin if co-prescribed)
  • Monitor closely for dehydration since the combination of SGLT2 inhibitor-induced osmotic diuresis plus diarrhea significantly increases volume depletion risk
  • Check kidney function as acute kidney injury has been reported with volume depletion in patients taking Farxiga 1
  • Consider temporarily holding Farxiga during acute diarrheal illness until volume status is restored

Important Caveat

If the patient is also taking metformin (a common combination in type 2 diabetes management 6), diarrhea is much more likely attributable to metformin, which causes GI side effects in a substantial proportion of patients 6. The 2025 ADA guidelines specifically note that metformin's GI side effects can be mitigated with slow dose titration, extended-release formulations, and administration with food 6.

Bottom line: Diarrhea should not be attributed to Farxiga itself, but any diarrhea in a patient taking this medication requires prompt attention due to the compounded dehydration risk.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.